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Abstract Determination of plasma creatinine (Pcr) should be
associated to an estimation of glomerular filtration rate
(eGFR). Pottel et al. established a height-independent equa-
tion, eGFR=107.3/(Pcr/Q) where Q is the median of Pcr
(Pottel–Belgium). The aims were to 1) determine a local
height-independent equation (Pottel–Lyon), 2) evaluate the
performance of these equations compared to the Schwartz
2009 and Schwartz–Lyon equations, and 3) evaluate the
height-independent equations in laboratory routine. There-
fore, 1) all first pediatric Pcr determination (December
2009–June 2011) were collected, and median of Pcr was
determined for each 1-year age interval (Q-Lyon), 2) GFR
was measured (mGFR) in 359 children (438 measures)
and compared to eGFR, and 3) all first Pcr determination
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(January 2012–June 2013) were used to calculate eGFR
with the Pottel–Lyon and the Pottel–Belgium equations.
Pcr was determined by an IDMS-standardized enzymatic
assay. In the population with a mGFR, the Pottel–Lyon
and the Schwartz–Lyon showed the best performance (bi-
as, P10 and P30). However, the performance in identify-
ing patients with a mGFR<75 mL/min/1.73 m2 was sim-
ilar for all the studied equations.
Conclusion: The performance of the height-independent
and dependent equations to identify mild renal dysfunction
is similar. The height-independent Pottel equation could be
proposed as an excellent screening tool for kidney disease
when height information is not available.
“What is Known:”
• Determination of plasma creatinine in children is rarely associated to
an estimation of glomerular filtration rate due to the lack of height
information.
• Pottel et al. developed a height-independent equation (eGFR=107.3/
(Pcr/Q) where Q is the median of Pcr for each age class.
“What is New:”
• The performance of the height-independent (Pottel) or height-dependent
(Schwartz) equations is similar to identify renal dysfunction
(GFR<75 mL/min/1.73 m2) in children.
• The height-independent Pottel equation could be an excellent screening
tool for kidney disease in a general pediatric laboratory when height
information is not available.
Keywords Children . Adolescents . Estimated glomerular
filtration rate . Height-independent GFR estimating equation .
Schwartz equation . Chronic kidney disease
Abbreviations
AUC Area under the curve
BMI Body mass index
BSA Body surface area
CCC Concordance correlation coefficient
CKD Chronic kidney disease
CKD-EPI Chronic kidney disease epidemiology
collaboration equation
eGFR Estimation of glomerular filtration rate
GFR Glomerular filtration rate
IDMS-traceable Pcr
determination
Traceable to an isotope dilution mass
spectrometry reference measurement
procedure
KDIGO Kidney disease improving global
outcomes
LOA Limit of agreement
MDRD Modification of diet in renal disease
equation
mGFR Measured GFR
Pcr Plasma creatinine
P10 10 % accuracy
P30 30 % accuracy
ROC Receiver-operator characteristic
SDS Standard deviation score
WHO World Health Organization
Introduction
There is a general consensus that screening for chronic kidney
disease (CKD) in adults is of great importance, and according
to the 2012 Clinical Practice Guidelines of the National Kid-
ney Foundation (Kidney Disease Improving Global Out-
comes; KDIGO) [17, 27], determination of plasma creatinine
(Pcr) should be associated to an estimation of glomerular fil-
tration rate (eGFR) with a GFR estimating equation based on
characteristics of the patient, that is sex, age, ethnic origin. In
the pediatric population, the last KDIGO recommends the use
of the Schwartz 2009 formula to estimate GFR in children.
However, this GFR predicting equation requires height infor-
mation, which is normally not available in clinical laboratory
databases. Therefore, Pcr determination is usually not associ-
ated to an eGFR which leads to miss many diagnosis of mild
or moderate CKD. Pottel et al. [14, 20] developed a height-
independent equation based on the determination of median
Pcr for each age class. The concept of this formula can be
applied in every laboratory with a large data base (i.e., large
laboratory pediatric hospital) leading to an equation adapted to
the laboratory and/or to the local population characteristics
(independent of ethnicity). As the original equation was de-
veloped in a European population with an IDMS-traceable Pcr
determination (traceable to an isotope dilution mass spectrom-
etry reference measurement procedure), the published coeffi-
cients could, from a theoretical point of view, be used in every
European laboratory if standardized Pcr method is used. Pottel
et al. claimed that this equation can be used as a screening tool
for a possible underlying kidney problem in a general popu-
lation of children [20]. Therefore, the aims of this study were
to estimate 1) the feasibility of determining a local height-
independent equation based on results of the laboratory hos-
pital; 2) the performance in estimating GFR and in identifying
patients with a CKD (i.e., GFR <75 or <60 mL/min/1.73 m2)
of the locally adapted (Pottel–Lyon), the original height-
independent equation (Pottel–Belgium), and the height-
dependent (Pottel–L–Belgium) eGFR formulas compared to
the internationally recommended Schwartz 2009 equation
[24] and the locally adapted Schwartz–Lyon equation [9]
(both height-dependent) in a population of children undergo-
ing a reference GFR measurement in our department; 3) the
practicability of using the height-independent GFR estimating
equation in children either with the original (Pottel–Belgium)
or the locally adapted (Pottel–Lyon) height-independent equa-
tion in laboratory routine.
Eur J Pediatr
Author's personal copy
Materials and methods
Clinical laboratory data set for determination
of the adapted Pottel–Lyon equation
The databases were obtained from the laboratory of the
pediatric hospital. All patient data were recorded in an
anonymous manner such that subjects could not be iden-
tified directly or through identifiers linked to the subjects.
The study was therefore exempted from institutional re-
view board. All Pcr value determined in children aged
between 1 and 18 years (either in outpatients or hospital-
ized ones) from December 2009 to June 2011 were col-
lected. Only the first test result for each patient was used
for further analysis. Also, data below the detection limit
(12 μmol/L) and outliers (determined by Grubbs test for
outliers) were not taken into account. This reduced the
total amount of data from n=80,668 to n=12,219. The
children were then further divided in subgroups according
to sex and age (age in years is calculated as (day of test−
day of birth)/365.25). Median Pcr values together with
lower and upper limits may be calculated using nonpara-
metric statistics (Pct 2.5 and Pct 97.5 are considered lower
and upper limits). This allowed to determine the Q-Lyon
value which is the median of healthy children at a specific
age in our laboratory.
Population of patients with a measured GFR
To evaluate the performance of GFR estimating equations,
we used a data set on 359 consecutive children (438 mea-
surements) referred to our center between January 2010
and July 2013 to undergo a GFR measurement (inulin or
iohexol clearance) as a routine procedure for renal evalu-
ation because of suspected underlying kidney pathology.
A written informed consent was obtained from all patients
or their families prior to obtaining the measured GFR
(mGFR). The consent form contained information refer-
ring to the procedure itself as well as the later use of the
information in research. According to the French Law,
concerning the use of a database without direct identifica-
tion of patients, it was not necessary to obtain an ethical
approval (law 2006–450, April 19th 2004; Commission
nationale de l’informatique et des libertés-CNIL). All pro-
cedures performed in this study were in accordance with
the ethical standards of the institutional and/or national
research committee and with the 1964 Helsinki declaration
and its later amendments or comparable ethical standards.
Weight, height, as well as standard deviation of size for age
(SDS) according to French pediatric growth charts [25], body
mass index (BMI), and BMI Z-score were recorded. Weight
categories were defined according to World Health Organiza-
tion (WHO) cutoff points for BMI (BMI Z-score<−2:
underweight patients, BMI Z-score between −2 and +2: nor-
mal weight, and BMI Z-score>+2: obese patients). Size cate-
gories were defined by a height<−2 SDS (undersized), be-
tween −2 and +2 SDS (normal size for age), and>+2SDS
oversized for age. All patients had concomitant determina-
tions of Pcr in our hospital laboratory allowing a GFR estima-
tion using the five formulas (Table 1).
Testing data set for determination of eGFR with the Pottel
equation in the general population
We determined eGFR with the height-independent GFR
predicting equation either with the previously determined Q-
Lyon value (Pottel–Lyon) or with the original Pottel formula
(Pottel–Belgium). All the first determinations of Pcr per-
formed in children in the laboratory of our hospital between
January 2012 and June 2013 were included.
GFR measurement and laboratory methods
GFR determination was measured either by renal inulin or
plasmatic iohexol clearance depending on the indication and
clinical condition of the patients. Plasmatic iohexol clearance,
which does not require urinary samples, was preferred in chil-
dren younger than 6 years of age or patients with urological
problems. By contrast, inulin clearance was chosen when a
history of iodine allergy, extracellular overload, or severe level
of CKD was present. However, as most studies indicate close
agreement between GFR measured by inulin clearance and
clearance of iohexol, measured as standard renal clearance
or plasma disappearance [23], we consider the two methods
as equivalent ones. A standard technique of renal clearance of
inulin (polyfructosan, Inutest®, Fresenius Kabi, Graz, Austria)
was used as previously described [9, 11]. The measurement of
plasma and urine polyfructosan concentrations were per-
formed using an enzymatic method which demonstrated very
good specificity and reproducibility (within-run precision
<1 % and between-run precision <3.5 %) [11]. Iohexol clear-
ance was performed according to a standard technique of
single-bolus injection method. Briefly, an IV injection of
about 6 mL/1.73 m2 (with a maximum dose of 6 mL) of
iohexol (Omnipaque, 300 mg/mL) was administered, and
blood samples were drawn from the contralateral arm after
120, 180, and 240min. The GFRwas calculated from the slope
of plasma concentrations using a one-compartment model
corrected using the Bröchner-Mortensen formula [3]. Plasma
iohexol concentration was determined using HPLC according
to the method published by Cavalier et al. [5] which showed
high analytical performances. External quality control was pro-
vided by Equalis (Uppsala, Sweden) every 3 months. The re-
sults were expressed per 1.73 m2 body surface area (Dubois
formula: BSA=height0.725×weight0.425×0.007184) [10].
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All Pcr determinations were obtained with an enzymat-
ic method (Multigent Creatinine Enzymatic kit purchased
from Abbott Diagnostics) on the Architect cSystemS. The
creatinine calibrators (ClinChem Cal) are traceable to the
National Institute of Standards and Technology, Creati-
nine Standard Reference Materials 914 (verified with
NIST SRM 967). Indicated quality control data showed
intra- and interassay precision (CV) of 0.6 and 2.6 %,
respectively at a creatinine concentration of 78 and
58 μmol/L, respectively.
Statistical analysis
The agreement between mGFR and eGFR values was evaluat-
ed by estimation of the mean bias (mean eGFR−mGFR), the
agreement limits, and the 10 % (P10) and 30 % (P30) accura-
cies as recommended by Earley et al. [12] and according to the
Clinical Practice Guidelines of the Kidney Disease Outcomes
Quality Initiative (KDOQI) [18]. A random intercept model
was used to estimate the mean bias and the standard deviation
(SD) of the bias. This allowed for repeated measurements in the
same patients and estimates of intra-patient and inter-patient
variances. The concordance correlation coefficient (CCC) was
used to test agreement [8, 15]. The ability of the formulas to
predict a mGFR<60, <75 and <90 mL/min/1.73 m2 was
assessed using area under the ROC curves (AUC).
To compare the mean biases, the CCCs, the P10, and the
P30, respectively, a paired t test, the bootstrap 95 % confi-
dence intervals of the differences between CCCs, and a
McNemar’s test were used.
Based on the paper of Hoste et al. [14], a performance score
for the eGFR formulas was calculated based on the following
rules:
(i) absolute bias <5: score +5; between 5 and 10: score +3;
between 10 and 15: score +1,
(ii) P30>80: score +5; between 70 and 80: score +3; be-
tween 60 and 70: score +1
(iii) P10>40: score +5; between 30 and 40: score +3; be-
tween 20 and 30: score +1.
All the analyses were performed using R for Windows,
version 3.0.2. Avalue of p<0.05 was considered for statistical
significance.
Results
Determination of median Pcr value in Lyon (Q-Lyon)
according to age class and sex in the clinical laboratory
data set population
Mean±SD, median, and percentile 2.5 and 97.5% of Pcr were
determined for each sex and for all 1 year interval age classes
(Table 2). Comparison of the median values for each age
and sex classes between the Belgian results of Pcr [21,
22] and those of our laboratory by a linear regression
slope showed a slight but significantly higher median re-
sult of Pcr in the Belgian population (slope 1.06,
p<0.0001). There is a 6 % systematic deviation between
median Pcr values (Q values) between Lyon and Belgium
with lower estimates for Lyon.
Performance of the GFR estimating equations
in the population of children with a mGFR
The performance of the height-independent equations (Pottel–
Lyon and Pottel–Belgium) and of the height-dependent equa-
tions (Schwartz 2009, Schwartz–Lyon, and Pottel–L–Bel-
gium) and formulas has been evaluated in a population of
359 children (438 measurements) referred to our department
for GFR determination. Characteristics of the children were
Table 1 Overview of eGFR equations
Name Full formula
Pottel–Lyon eGFR=107.3/(Scr/Q) with
Q=median of Pcr of healthy children at a specific age (Table 2)
Pottel–Belgium [14] eGFR=107.3/(Scr/Q) with
Q=88.4×(0.21+0.057×Age−0.0075×Age2+0.00064×Age3−0.000016×Age4) for boys
Q=88.4×(0.23+0.034×Age−0.0018×Age2+0.00017×Age3−0.0000051×Age4) for girls
Pottel–L–Belgium [14] eGFR=107.3/(Pcr/Q) with
Q=88.4×(3.94–13.4×L+17.6×L2−9.84 L3+2.04×L4) for boys and girls
Schwartz 2009 [24] eGFR=36.5×L / PCr
Schwartz–Lyon [9] eGFR=k×L/PCr
k=36.5 in males aged >13 years
k=32.5 in others
L=Height, expressed in centimeter (cm) except for Pottel–L–Belgium where height is expressed in meter (m); PCr=Plasma creatinine, expressed in
micromoles per liter (μmol/L) and age in years
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indicated in Table 3. Schwartz–Lyon and Pottel–Lyon showed
the best performance in the whole population and in patients
with a GFR <90 mL/min/1.73 m2 giving significantly higher
P30 and CCC and lower bias in comparison with other equa-
tions (Table 4). In patients with a GFR≥90 mL/min/1.73 m2,
the performance of the five predicting GFR equations is sim-
ilar. To note, hyperfiltration (GFR ≥135 mL/min/1.73 m2) [4]
that was observed in 39 patients (42 measurements, mean
GFR=153 mL/min/1.73 m2) decreased performance (bias,
P10 and P30) of all studied equations (data not shown). A
performance score for the five different eGFR formulas in
the whole population and in each subgroup (defined by a
GFR<90 or ≥90 mL/min/1.73 m2 was calculated (Table 4).
In the overall cohort, as well in the two mGFR subgroups, the
Schwartz–Lyon and the Pottel–Lyon get the highest score.
As shown by the areas under the ROC curves of
GFR estimating equations (Table 5), all the studied
equations have similar performance in identifying pa-
tients with renal dysfunction (mGFR<60 or <75 mL/
min/1.73 m2) in the present study. However, when
mGFR<90 mL/min per 1.73 m2, the AUC of Schwartz
2009 and Schwartz–Lyon formulas were significantly
higher than those of the others formulas. Bland and
Altman graphs show bias changes according to mGFR:
the overestimation of mGFR increased when mGFR de-
creased with all equations (Fig. 1).
Finally, the performance of eGFR equations was
evaluated according to weight and size subgroups
(Table 6). All the equations have better performance in
the normal group of weight or size. However, Pottel–
Lyon and Schwartz–Lyon have a better score in all the
subgroups, followed by the Pottel–L–Belgium equation.
The performance of Schwartz 2009 and Pottel–Belgium
are rather similar.
Determination of eGFR in the testing data set of children
All the first Pcr measurements of 13,117 children (53.3 % of
males) aged 8.7±5.2 years (1–18) were included. Mean Pcr
was 55±28 μmol/L. Among them, 328 (2.5 %) and 949
(7.2 %) children have a Pcr value less the 2.5th and above
the 97.5th percentile for age and sex, respectively. P97.5 cor-
responds to a mean eGFR of 76.4±3.4 mL/min/1.73 m2 (70–
83) with Pottel–Lyon and a Pcr/Q of 1.41±0.06 (1.3–1.5).
Three thousand one hundred and four (23.7 %) and 908
(6.9 %) of children have a Pottel–Lyon estimated eGFR <90
and <75 mL/min/1.73 m2, respectively.
Table 2 Mean, median, and lower and upper limit of Pcr in the training set population in Lyon (n=12,219) and median of Pcr in Belgium (Q-Belgium)
for different age categories
Girls Boys
Lyon Belgium Lyon Belgium
Age group
(years)
Number Mean
Pcr±SD
Median Pcr=Q-Lyon
[P2.5–P97.5]
Median Pcr Q-
Belgium
Number Mean
Pcr±SD
Median Pcr=Q-Lyon
[P2.5–P97.5]
Median Pcr Q-
Belgium
1–2 682 22.9±4.5 22 [15–33] 24 765 23.1±4.9 23 [15–35] 24
2–3 504 24.9±5.1 25 [15–35] 27 547 25.3±5.3 25 [15–36] 27
3–4 332 27.6±5.4 27 [17–40] 29 439 27.7±5.2 28 [18–39] 29
4–5 356 29.7±5.7 30 [19–41] 32 389 30.8±5.9 30 [19–43] 32
5–6 299 31.9±5.8 31 [23–44] 34 382 32.7±6.3 32 [21–46] 34
6–7 249 34.2±6.6 34 [22–50] 37 334 34.1±6.9 34 [19–47] 37
7–8 300 36.9±6.6 36 [26–51] 39 323 38.2±6.7 38 [25–53] 39
8–9 307 38.9±6.8 39 [26–52] 40 327 40.4±7.4 40 [24–56] 40
9–10 272 40.9±7.5 40 [27–57] 43 310 41.8±6.9 42 [27–56] 43
10–11 291 41.8±7.9 41 [27–60] 46 353 44.7±7.3 44 [30–58] 46
11–12 276 43.7±6.6 43.5 [30–59] 47 355 46.5±7.2 46 [32–60] 47
12–13 261 46.6±7.6 46 [34–62] 50 375 47.5±8.4 48 [32–65] 50
13–14 307 48.5±9.5 48 [32–71] 54 334 52.8±9.6 52 [36–78] 54
14–15 332 53.0±8.8 52.5 [36–70] 55 369 57.0±11.2 57 [37–79] 60
15–16 399 55.1±9.2 55 [38–76] 59 382 63.9±12.4 64 [39–90] 69
16–17 302 56.5±9.2 56 [41–77] 62 236 68.6±11.8 69 [44–91] 72
17–18 292 57.1±10.1 57 [37–81] 62 238 72.2±11.9 72 [46–93] 75
Pcr is expressed in micromoles per liter (μmol/L)
P2.5 percentile 2.5, P97.5 percentile 97.5
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Mean±SD eGFR estimated with Pottel–Lyon was signifi-
cantly lower than those estimated with Pottel–Belgium (106.3
±28.6 and 115.1±30.9 mL/min/1.73 m2, respectively,
p<0.0001). The difference between the two estimating formu-
lae was −8.4±3.8 % and do not change with the Pcr/Q ratio.
The use of Q-Belgium to estimate eGFR leads to a change of
classification between decreased (eGFR<90) to normal eGFR
(eGFR≥90) in 1315 children. However, mean Pottel–Lyon
estimated eGFR of these 1315 patients was 86.3±2.7 mL/
min/1.73 m2 (78.6–89.9) that is close to the limit of 90.
Discussion
Pcr measurement is one of the most frequent biochemical
parameters measured in patients even in children. However,
eGFR is rarely determined by the laboratory due to the lack of
height information, a necessary parameter in the Schwartz
2009 formula. To help clinicians, reference intervals of Pcr
according to sex and age are provided such as those provided
by Pottel et al. or Ceriotti et al. [6, 22]. However, identifying a
mild or moderate CKD is challenging, and the use of a height-
independent formula might be useful.
According to international recommendations, Pcr measure-
ment in children should be performed by an enzymatic method
with calibration traceable to IDMS reference methodology [17]
in order that results could be compared in all laboratories of most
countries. Therefore, provided that the studied population is sim-
ilar to the reference group, the use of GFR estimating equations
with identical coefficients could be used with a relative confi-
dence. In the present study, the predicting GFR equations (i.e.,
Schwartz 2009 and Pottel–Belgium or Pottel–L–Belgium)
established in other countries (USA and Belgium, respectively)
with comparable Pcr method of measurements and in compara-
ble populations (Western countries children), give similar perfor-
mance results. The good performance of Schwartz 2009, Pottel–
Belgium, and Pottel–L–Belgium in our study is in accordance
with previous reports [1, 11, 14, 24, 26].
Table 3 Characteristics of the
patients with GFR measurement Characteristic of the patients Database
n 359
Male (%) 58 %
Age (years) 9.5±3.3 (3–18)
Weight (kg) 30.5±13.2 (9–92)
Height (cm) 131.3±18.9 (77–182)
Height expressed in SDS 0.2±1.5(−6.5–4.2)
Growth retardation (<2SDS) 35 (8.0 %)
Growth advance (>2SDS) 26 (5.9 %)
BMI (kg/m2) 17±3 (10–32)
BMI Z-score 0.07±1.4 (−4.9–5.2)
Underweight (BMI Z-score<−2) 25 (5.7 %)
Obese (BMI Z-score>2) 36 (8.2 %)
Method of GFR measurement (inuline/iohexol) (%) 43 %/57 %
Plasma creatinine (μmol/L) 55±28 (17–262)
mGFR (mL/min/1.73 m2) 95±29 (18–204)
Indications of GFR measurement
Congenital abnormality of the kidney and urinary tract 105 (29 %)
Glomerular nephropathy 40 (11 %)
Tubulo-interstial disease 19 (5 %)
Hereditary disease 22 (6 %)
Renal transplantation 44 (13 %)
Other transplantation 76 (21 %)
Other 53 (15 %)
CKD classification
Stage I 204 (57 %)
Stage II 104 (29 %)
Stage III 44 (12 %)
Stage IV 7 (2 %)
Values are mean±standard deviation (range) or n (%) unless otherwise specified
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However, a 6 % systematic deviation between median Pcr
values (Q values) between Lyon and Belgium was observed
with a mean difference between Q values for Lyon and Bel-
gium of −2.7±1.5 μmol/L (−6 to 0), p<0.0001, leading to a
small but significant difference in the mean eGFR estimation
in the testing population with either the Pottel–Lyon or the
Pottel–Belgium. Despite standardization of Pcr measurement
method, this systematic deviation might be partly explained
by the use of various manufacturer techniques of Pcr measure-
ment (Roche enzymatic assay in Belgium, Abbott enzymatic
assay in Lyon). In addition, differences (i.e., median size and
height) between children from different European countries
cannot be ruled out as suggested by Bonthuis et al. who re-
ported a difference in mean height between Belgium and
France [2]. These small but significant differences might ex-
plain the better performance of Pottel–Lyon which uses the
locally adapted coefficient for our own children population.
However, these differences are not significant on a clinical
point of view. The same points (i.e., difference of Pcr mea-
surement method and/or anthropometric differences between
Table 5 Performance of the formulas in identifying patients with mGFR <60, GFR <75, and <90 mL/min /1.73 m2
GFR <60 mL/min/1.73 m2n=69 (65) GFR <75 mL/min/1.73 m2 n=130 (98) GFR <90 mL/min/1.73 m2 n=206 (163)
Formula AUC (95 % CI) Std. Error AUC (95 % CI) Std. Error AUC (95 % CI) Std. Error
Schwartz 2009 0.95 (0.92, 0.98) 0.02 0.94 (0.91, 0.96) 0.01 0.91 (0.88, 0.94) * 0.01
Schwartz–Lyon 0.95 (0.91, 0.98) 0.02 0.93 (0.90, 0.96) 0.01 0.91 (0.88, 0.93) * 0.01
Pottel–Lyon 0.94 (0.91, 0.97) 0.02 0.92 (0.89, 0.95) 0.01 0.88 (0.85, 0.91) 0.02
Pottel–Belgium 0.94 (0.90, 0.97) 0.02 0.91 (0.88, 0.94) 0.02 0.87 (0.84, 0.91) 0.02
Pottel–L–Belgium 0.95 (0.92, 0.98) 0.02 0.93 (0.90, 0.95) 0.01 0.89 (0.87, 0.93) 0.01
AUC area under ROC curves, 95 % CI 95 % confidence interval
*p<0.05 between Schwartz 2009 and other formulas, favoring Schwartz 2009 (without difference for Schwartz–Lyon) n=Number of measurements
(patients)
Table 4 Statistical results for the prediction performance of eGFR equations and results of the performance scoring system (results between brackets)
according to mGFR, subgroups
Group Schwartz 2009 Schwartz–Lyon Pottel–Lyon Pottel–Belgium Pottel–L–Belgium
All measurements (n=438/patients=359)—mGFR±SD=92.9±32.6
Bias±SD 10.0±22.7 (3) −0.5±21.6* (5) 0.3±21.4* (5) 8.2±23.3 (3) 4.4±21.9 (5)
30 % accuracy 81.0 (5) 87.6 * (5) 87.0 * (5) 79.6 (3) 85.2 (5)*
10 % accuracy 36.5 (3) 42.4 (5) 43.0 (5) 37.4 (3) 38.8 (3)
CCC 0.77 (0.73–0.80) 0.81 (0.77–0.84) * 0.80 (0.76–0.83) * 0.75 (0.71–0.79) 0.79 (0.76–0.82)*
Scorea 11 15 15 9 13
According to mGFR
Group 1 (GFR<90 mL/min/1.73 m2) (n=206/patients=163)—mGFR±SD=65.3±17.1
Bias±SD 12.4±18.7 (1) 5.0±16.8* (3) 7.4±16.8* (3) 14.0±18.7 (1) 9.1±17.3 (3)
30 % accuracy 74.8 (3) 85.4 * (5) 82.5* (5) 70.0 (3) 81.5 (5)
10 % accuracy 34.5 (3) 40.8 (5) 42.2 (5) 37.9 (3) 36.9 (3)
Scorea 7 13 13 7 11
Group 2 (GFR≥90 mL/min/1.73 m2) (n=232/patients=209)—mGFR±SD=117.4±21.3
Bias±SD 8.1±25.7 (3) −4.7±23.2 (5) −5.1±23.1(3) 4.0±25.7 (5) 0.9±24.7 (5)
30 % accuracy 86.6 (5) 90.0 (5) 91.0 (5) 88.3 (5) 88.8 (5)
10 % accuracy 38.7 (3) 44.3 (5) 43.1 (5) 37.0 (3) 36.9 (3)
Scorea 11 15 13 13 13
mGFR is expressed in mL/min/1.73 m2
SD standard deviation, CCC concordance correlation coefficient
*p<0.05 between Schwartz–Lyon and other equations, favoring Schwartz–Lyon, but without difference with Pottel–Lyon
a Performance score for the eGFR formulas in the three subgroups according to Hoste et al.[14] and based on the following rules: (i) absolute bias <5:
score +5; between 5 and 10: score +3; between 10 and 15: score +1, (ii) P30>80: score +5; between 70 and 80: score +3; between 60 and 70: score +1,
and (iii) P10>40: score +5; between 30 and 40: score +3; between 20 and 30: score +1
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children population) could explain the small but significant
better performance of the locally adapted Schwartz–Lyon for-
mula compared to Schwartz 2009. However, the performance
of the adapted Pottel–Lyon and Schwartz–Lyon equations is
similar.
The height-independent Pottel equation is built on the con-
cept of a population-normalized Pcr and median Pcr (Q value)
for age and sex can reliably be obtained from large hospital
laboratory databases, as the majority of patients in these data-
bases have normal kidney function [20]. In addition, with the
systematic exclusion of patients with serial measurements and
the use of specific statistical methods (a nonparametric meth-
od, the Bhattacharya procedure, and a nonlinear fit of the
cumulative Gaussian distribution) which allowed to
distinguish the normal from the abnormal data of Pcr, we
can establish reliable and robust data of normal Pcr according
to sex and age in a healthy population of children. However, in
the testing data set as 7.2 % of children have a Pcr value above
the 97.5 percentile for age and sex. This result could be ex-
plained by the fact that all first Pcr measurements of the pedi-
atric hospital database were included, that is an increased pro-
portion of children with an elevated Pcr compared to a normal
healthy population.
In our population, 2155 (16.4 %) of children have a mild
CKD according to the Pottel–Lyon equation (stage 2 of
KDIGO classification) with a Pcr below the 97.5th percentile.
In another way, 23.7 % of children of our testing set popula-
tion have a Pottel–Lyon eGFR<90 mL/min/1.73 m2 and
Fig. 1 Bland and Altman plots
showing, for each formula, the
estimated GFR minus the
measured GFR bias in function of
the measured GFR as gold
standard in the whole population
of children with a mGFR
determination. The solid line
represents the mean ratio. The
broken lines represent the 95 %
limits of agreement (i.e., ±1.96×
the standard deviation)
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6.9 % an eGFR<75 mL/min/1.73 m2. These results are in
accordance with those of Fadrowski et al. [13] who found that
8.9 % of adolescents from the National Health and Nutrition
Examination Survey (NHANES), in the USA, had an eGFR<
75 mL/min/1.73 m2 (the reporting cutoff used by pediatric
eGFR calculators on the National Kidney Disease Education
Program (NKDEP) web site) when the bedside Schwartz 2009
formulae is used. Chavers et al. found comparable results with
the Chronic Kidney Disease in Children formula, which
includes Pcr, cystatin C, and blood urea nitrogen concentra-
tion [7].
Finally, we can demonstrate that all the studied equations
have a better performance in children with a normal weight
and/or size for age and that the performance of most of the
equations decreases in children with extreme size and/or BMI.
Therefore, the height-independent equation, with or with-
out an adaptation to the local laboratory, could be used as
screening tool in a general population and as a warning sign
Table 6 Statistical results for the prediction performance of eGFR equations and results of the performance scoring system (results between brackets)
according to weight and height subgroups
Group Schwartz 2009 Schwartz–Lyon Pottel–Lyon Pottel–Belgium Pottel–L–Belgium
According to weight
Obesity (n=36/patients=32)—mGFR±SD=92.2±28.4
Bias±SD 14.2±27.5 (1) 3.0±24.5 (5) 2.6±24.8 (5) 11.5±25.8 (1) 9.6±26.0 (3)
30 % accuracy 69.4 (1) 83.3 (5) 83.3 (5) 63.9 (1) 77.8 (3)
10 % accuracy 27.8 (1) 38.9 (3) 33.3 (3) 22.2 (1) 30.6 (3)
Scorea 3 13 13 3 9
Normal weight (n=377/patients=311)—mGFR±SD=95.3±32.9
Bias±SD 8.9±22.3 (3) −1.4±20.7 (5) −0.8±20.5 (5) 6.9±22.3 (3) 3.2±21.5 (5)
30 % accuracy 83.6 (5) 88.6 (5) 88.1 (5) 82.2 (5) 86.7 (5)
10 % accuracy 38.5 (3) 42.2 (5) 44.6 (5) 40.6 (5) 40.3 (5)
Scorea 11 15 15 13 15
Underweight (n=25/patients=22)—mGFR±SD=90.4±30.0
Bias±SD 17.6±23.1 (0) 7.0±20.2 (3) 13.4±25.6 (1) 23.3±29.4 (0) 13.9±22.4 (1)
30 % accuracy 60.0 (0) 80.0 (3) 72.0 (3) 64.0 (1) 72.0 (3)
10 % accuracy 24.0 (1) 44.0 (5) 28.0 (1) 12.0 (0) 28.0 (1)
Scorea 1 11 5 1 5
According to size
Oversized for age (n=26/patients=24)—mGFR±SD=107.3±33.2
Bias±SD 25.9±29.5(0) 11.8±24.8 (1) 1.5±22.4 (5) 10.4±24.3 (1) 18.4±27.8 (0)
30 % accuracy 53.8 (0) 80.8 (5) 92.3 (5) 76.9 (3) 61.5 (1)
10 % accuracy 30.8 (3) 30.8 (3) 38.5 (3) 34.6 (3) 23.1 (1)
Scorea 3 9 13 7 2
Normal size for age (n=377/patients=311)—mGFR±SD=95.0±31.9
Bias±SD 9.2±22.3 (3) −1.1±20.8* (5) −0.6±21.4* (5) 7.2±23.2 (3) 3.6±21.6 (5)
30 % accuracy 83.0 (5) 88.3 (5) 87.0 (5) 80.9 (5) 86.7 (5)
10 % accuracy 36.9 (3) 44.3 (5) 43.0 (5) 37.7 (3) 40.8 (5)
Scorea 11 15 15 11 15
Short size for age (n=35/patients=31)—mGFR±SD=81.7±31.8
Bias±SD 4.0±16.6 (5) −3.9±16.8 (5) 9.1±19.4 (3) 17.6±21.7 (0) 0.7±16.8 (5)
30 % accuracy 80.0 (3) 85.7 (5) 80.0 (3) 68.6 (1) 85.7 (5)
10 % accuracy 40.0 (3) 25.7 (1) 42.9 (5) 37.1(3) 28.6 (1)
Scorea 11 11 11 4 11
mGFR is expressed in mL/min/1.73 m2
SD standard deviation, CCC concordance correlation coefficient
*p<0.05 between Schwartz–Lyon and other equations, favoring Schwartz–Lyon, but without difference with Pottel–Lyon
a Performance score for the eGFR formulas in the three subgroups according to Hoste et al. [14] and based on the following rules: (i) absolute bias <5:
score +5; between 5 and 10: score +3; between 10 and 15: score +1, (ii) P30>80: score +5; between 70 and 80: score +3; between 60 and 70: score +1,
and (iii) P10>40: score +5; between 30 and 40: score +3; between 20 and 30: score +1
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for a possible underlying kidney problem. Pediatric consider-
ations of KDIGO guidelines [19] recommend to report an
individual child’s eGFR value of less than 60 mL/min/
1.73 m2 as “decreased.” However, according to KDIGO
[16], pediatric practice would suggest a higher level of kidney
function for referral than that for adults, although there is no
specific value in children. As suggested in a recent paper [19],
abnormal GFR in children and adolescents starts below
75 mL/min/1.73 m2; we can suggest that all children with an
eGFR<75mL/min per 1.73 m2 could be indicated to the prac-
titioner as potentially decreased GFR. This may trigger the
attention of the general practitioner and may be the reason
for sending this particular child to the pediatric nephrologist
as for adult patients with the MDRD or CKD-EPI.
Several strengths of the present study can be pointed out: 1)
the use of a reference standard method for GFR measurement
(i.e., inulin or iohexol clearance) to evaluate performance of
the various GFR estimating equations; 2) the use of an IDMS-
standardized Pcr to validate the Pottel–Belgium, the Pottel–L–
Belgium, and Schwartz 2009 equations; and 3) the demonstra-
tion of the practicability of determining an adapted height-
independent equation to the local method of determination
of Pcr and to the anthropometric characteristics of the French
children population and its performance. However, the study
presents also some limitations: 1) the lower age limit of
2.7 years of the children with a measured GFR limiting the
validity of our results for children aged between 1 and 3 years;
2) the effect of ethnicity could not be tested because this in-
formation was not regularly available for all patients.
Conclusion
The performance of the height-independent equation is similar
to those of the Schwartz 2009 or Pottel–L–Belgium equation
in a Western country population of children when IDMS-
standardized Pcr determination is used. Therefore, this equa-
tion could be easily used by every laboratory to give an eGFR
in children and provide a screening tool to detect CKD in a
general population of children.
This study demonstrates that the Q coefficient can be lo-
cally determined by large laboratories leading to a better per-
formance of the locally adapted Pottel equation. A locally
adapted equation might be very useful when enzymatic Pcr
determination is not possible and/or in other population
preventing the inappropriate use of formula established in
Western countries patients.
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